Toxic Epidermal Necrolysis
📧 Sign up to get email alerts when something new happens for Toxic Epidermal Necrolysis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies. [Phase 1, Phase 2]
A Phase 1/2 trial is investigating anti-CD38+ monoclonal antibodies as a new therapeutic target for Toxic Epidermal Necrolysis, with the stu…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and potential efficacy of a cell therapy in patients with cicatricial conjunctivitis and re…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Severe Bullous Drug Eruption and Filgrastim [Phase 2, Phase 3]
The document announces ongoing Phase 2 and Phase 3 recruitment for a clinical trial evaluating filgrastim in patients with toxic epidermal n…
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: Severe Cutaneous Adverse Reactions in Thailand
This clinical trial update from Thailand reports on severe cutaneous adverse reactions, including Stevens-Johnson Syndrome and Toxic Epiderm…